ivim tirzepatide shortage Ivím Health Raises Alarm as FDA Deadline Threatens Obesity Treatment Access GLP-1 Weight Loss Therapy with

It works by targeting the GLP-1 hormone involved in appetite regulation, helping to increase feelings of fullness, and is used alongside a healthy diet and lifestyle, following a clinical assessment

Farxiga (Dapagliflozin) Farxiga sales in 2022: $4.381 billion Company/Developer: AstraZeneca Date of first FDA approval: January 8, 2014 Indications Farxiga is FDA-approved for: Type 2 diabetes, reducing risk of heart failure, chronic kidney disease (regardless of diabetic status) Price of Farxiga: About $623 for a supply of 30 oral 10 mg tablets Why it did so well: Farxiga is a SGLT2 inhibitor used primarily for the treatment of type 2 diabetes

Skin Brightening: Reduces melanin production to lighten and even out skin tone, fading dark spots and hyperpigmentation

L-carnitine may benefit:[2] Recovery : Improves muscle recovery after intense training

Both medicines are used for blood sugar and weight management in people with type 2 diabetes and excess weight or obesity

Individual responses to semaglutide vary, and achieving weight loss or managing blood sugar levels can take time